Literature DB >> 4197360

Sensitization to epinephrine-induced ventricular fibrillation produced by probucol in dogs.

F N Marshall, J E Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4197360     DOI: 10.1016/0041-008x(73)90221-4

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  6 in total

Review 1.  Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

2.  Cardiac sensitization induced by phenobarbitone and prolonged by CS2.

Authors:  I Eastwood; P J Forshaw; J Jeyeratnam; L Magos
Journal:  Arch Toxicol       Date:  1977-07-19       Impact factor: 5.153

3.  Electrocardiographic effects of probucol. A controlled prospective clinical trial.

Authors:  C A Dujovne; F Atkins; B Wong; S DeCoursey; P Krehbiel; S B Chernoff
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Factors related to QT interval prolongation during probucol treatment.

Authors:  Y Ohya; K Kumamoto; I Abe; Y Tsubota; M Fujishima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.